MARKET

PAVMZ

PAVMZ

PAVMED
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.810
+0.120
+4.46%
Closed 16:00 05/18 EDT
OPEN
2.510
PREV CLOSE
2.690
HIGH
2.835
LOW
2.390
VOLUME
19.34K
TURNOVER
--
52 WEEK HIGH
4.900
52 WEEK LOW
0.7100
MARKET CAP
--
P/E (TTM)
-3.7896
1D
5D
1M
3M
1Y
5Y
PAVmed Provides Business Update and First Quarter 2021 Financial Results
Conference call to be held today at 4:30 PM EDT
GlobeNewswire · 1d ago
PAVmed Subsidiary Lucid Diagnostics Announces Upcoming Presentation at Digestive Disease Week 2021
Dr. David Poppers to present on his initial experience with Lucid’s EsoCheck and EsoGuard NEW YORK, May 13, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed” or the “Company”), a highly differentiated, multi-product, commercial-stage med...
GlobeNewswire · 5d ago
PAVmed Subsidiary Lucid Diagnostics Expands Commercial Leadership Team
Four new senior executives will support growth strategy focused on multi-channel EsoGuard commercialization
GlobeNewswire · 05/06 13:30
PAVmed to Hold Business Update Conference Call on May 17, 2021
Company conference call and webcast at 4:30 PM EDT
GlobeNewswire · 05/03 13:30
BRIEF-Pavmed Retires Convertible Debt
reuters.com · 03/03 17:23
BRIEF-PAVmed Announces Pricing Of $45 Million Public Offering Of Common Stock
reuters.com · 02/23 14:01
BRIEF-PAVmed Reports Proposed Public Offering Of Common Stock
reuters.com · 02/22 22:01
BRIEF-PaVmed Quarterly GAAP Loss Per Share $0.17
reuters.com · 02/22 15:40
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of PAVMZ. Analyze the recent business situations of PAVMED through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
EPS
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+0.31%
Healthcare Equipment & Supplies
+0.36%
Key Executives
Chairman/Chief Executive Officer/Director
Lishan Aklog
President/Chief Financial Officer/Secretary
Dennis McGrath
President/Chief Financial Officer/Secretary
Dennis Mcgrath
Vice Chairman/Independent Director
Michael Glennon
Other
Brian DeGuzman
Director
Debra White
Independent Director
David Battleman
Independent Director
James Cox
Independent Director
Ronald Sparks
Independent Director
David Weild
No Data
About PAVMZ
PAVmed Inc. is a medical device company organized to conceive, develop and commercialize a diversified pipeline of products. The Company's products include PortIO, Caldus, CarpX, NextCath, DisappEAR and NextFlo. PortIO is an implantable vascular access device, which does not require accessing the central venous system and does not have an indwelling intravascular component. CarpX is a percutaneous device to treat carpal tunnel syndrome. NextCath is a self-anchoring catheter, which does not require suturing, traditional anchoring techniques or add-on catheter securement devices. The Company's DisappEAR is an Antibiotic-eluting Resorbable Ear Tubes. The Company is engaged in developing and commercializing antibiotic-eluting resorbable ear tubes based on an aqueous silk technology conceived and developed at these institutions. The Company is engaged in developing disposable infusion system with variable flow resistors. Caldus is a disposable tissue ablation device.

Webull offers kinds of PAVmed Inc stock information, including NASDAQ:PAVMZ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PAVMZ stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PAVMZ stock methods without spending real money on the virtual paper trading platform.